22 August 2018
Visiongain’s new report Global Medical Device Contract Manufacturing Market Forecast 2017-2027: Electronic Manufacturing Services, Materials Processing, Finished Products, Medical Diagnostic Devices, Monitoring & Surgical Equipments, Therapeutic Devices indicates that the global medical device contract manufacturing market will see $102.9bn in spending in 2021.
The lead analyst of the report said: ““The global market for medical device contract manufacturing in 2016 was valued at $63.0bn. Outsourcing of various processes in the medical device development cycle is now seen as an essential strategy by OEMs to ensure return on investment. The medical device contract manufacturing market is highly fragmented, with several thousand companies providing a range of services from machining, moulding, stamping, assembly, to packaging. The industry has many small organisations generating revenue of less than $5m annually. These organisations tend to be specialists in one technology. There are also several large CMOs generating revenues of over $100m. The medical device contract manufacturing industry has witnessed consolidation and increasing business from the OEMs. Although there are still many small companies with less than $5m in revenues, the industry is expected to witness more consolidation in the near future, visiongain believes.”
The 247-page report contains 75 tables and 95 figures that add visual analysis in order to explain developing trends within the Global Medical Device Contract Manufacturing market. Visiongain provides revenue forecasts for the period 2017-2027 as well as qualitative analyses for the leading segments of this market: Electronic Manufacturing Services, Materials Processing and Finished Products.
The 247-page report offers market forecasts and analysis for the leading medical device contact manufacturing national markets: the US, Japan, EU5 (the UK, Germany, France, Spain, and Italy), China, Central America & South America, India and Rest of the World
In addition, the report contains a dedicated leading companies’ chapter covering the leading companies in the medical device contract manufacturing market:
The Global Medical Device Contract Manufacturing Market Forecast 2017-2027: Electronic Manufacturing Services, Materials Processing, Finished Products, Medical Diagnostic Devices, Monitoring & Surgical Equipments, Therapeutic Devices report will be of value to anyone who wants to better understand the medical device contract manufacturing market and its various segments. It will be useful for businesses who wish to better comprehend the part of the market they are already involved in, or those wishing to enter or expand into a different regional or technical part of the medical device contract manufacturing industry.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44 (0) 207 336 6100
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to-business conferences, newsletters, management reports and e-zines focusing on the automotive, chemical, cyber, defence, energy, pharmaceutical, materials and telecoms sectors.
Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
The 431-page report provides clear detailed insight into the generic drugs market. Discover the key drivers and challenges affecting the market.
03 July 2020
Where is the Clinical Workflow Solutions market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.
03 July 2020
With the growing burden of rare diseases around the world, there has been a rise and advancement in the therapy development of these types of diseases. While the fact remains that over 90% of these diseases lack approval for treatment and the total number of terminal rare diseases to receive the first treatment every year remains low.
01 July 2020
The market growth is attributed to the growing adoption of big data and AI in data management and monitoring of clinical information in health care.